Our group works on establishing PK/PD relationships for therapeutics to treat enteric pathogens. We are currently focusing on drugs to treat Cryptosporidium and Shigella. We assist in the pre-clinical stages of drug development by generating in vitro and in vivo models to characterize drug efficacy against enteric pathogens.

In addition, we support clinical pharmacology efforts on clinical trials in these disease areas.

Diseases we study